6.
Pagliuca S, Gurnari C, Hercus C, Hergalant S, Nadarajah N, Wahida A
. Molecular landscape of immune pressure and escape in aplastic anemia. Leukemia. 2022; 37(1):202-211.
PMC: 10089624.
DOI: 10.1038/s41375-022-01723-w.
View
7.
Narita A, Muramatsu H, Sekiya Y, Okuno Y, Sakaguchi H, Nishio N
. Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemia. Haematologica. 2015; 100(12):1546-52.
PMC: 4666330.
DOI: 10.3324/haematol.2015.132530.
View
8.
Brummendorf T, Maciejewski J, Mak J, Young N, Lansdorp P
. Telomere length in leukocyte subpopulations of patients with aplastic anemia. Blood. 2001; 97(4):895-900.
DOI: 10.1182/blood.v97.4.895.
View
9.
Savage S, Viard M, OhUigin C, Zhou W, Yeager M, Li S
. Genome-wide Association Study Identifies HLA-DPB1 as a Significant Risk Factor for Severe Aplastic Anemia. Am J Hum Genet. 2020; 106(2):264-271.
PMC: 7010969.
DOI: 10.1016/j.ajhg.2020.01.004.
View
10.
Loh P, Genovese G, McCarroll S
. Monogenic and polygenic inheritance become instruments for clonal selection. Nature. 2020; 584(7819):136-141.
PMC: 7415571.
DOI: 10.1038/s41586-020-2430-6.
View
11.
Wang Y, McReynolds L, Dagnall C, Katki H, Spellman S, Wang T
. Pre-transplant short telomeres are associated with high mortality risk after unrelated donor haematopoietic cell transplant for severe aplastic anaemia. Br J Haematol. 2019; 188(2):309-316.
PMC: 6980174.
DOI: 10.1111/bjh.16153.
View
12.
Gadalla S, Wang T, Dagnall C, Haagenson M, Spellman S, Hicks B
. Effect of Recipient Age and Stem Cell Source on the Association between Donor Telomere Length and Survival after Allogeneic Unrelated Hematopoietic Cell Transplantation for Severe Aplastic Anemia. Biol Blood Marrow Transplant. 2016; 22(12):2276-2282.
PMC: 5116252.
DOI: 10.1016/j.bbmt.2016.09.012.
View
13.
Olson T, Frost B, Duke J, Dribus M, Xie H, Prudowsky Z
. Pathogenicity and impact of HLA class I alleles in aplastic anemia patients of different ethnicities. JCI Insight. 2022; 7(22).
PMC: 9746824.
DOI: 10.1172/jci.insight.163040.
View
14.
Blackburn E, Epel E, Lin J
. Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection. Science. 2016; 350(6265):1193-8.
DOI: 10.1126/science.aab3389.
View
15.
Betensky M, Babushok D, Roth J, Mason P, Biegel J, Busse T
. Clonal evolution and clinical significance of copy number neutral loss of heterozygosity of chromosome arm 6p in acquired aplastic anemia. Cancer Genet. 2015; 209(1-2):1-10.
PMC: 4738084.
DOI: 10.1016/j.cancergen.2015.10.002.
View
16.
Maciejewski J, Risitano A, Sloand E, Nunez O, Young N
. Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia. Blood. 2002; 99(9):3129-35.
DOI: 10.1182/blood.v99.9.3129.
View
17.
Brown D, Zhou W, Wang Y, Jones K, Luo W, Dagnall C
. Germline-somatic JAK2 interactions are associated with clonal expansion in myelofibrosis. Nat Commun. 2022; 13(1):5284.
PMC: 9458655.
DOI: 10.1038/s41467-022-32986-7.
View
18.
Brown D, Lin S, Loh P, Chanock S, Savage S, Machiela M
. Genetically predicted telomere length is associated with clonal somatic copy number alterations in peripheral leukocytes. PLoS Genet. 2020; 16(10):e1009078.
PMC: 7608979.
DOI: 10.1371/journal.pgen.1009078.
View
19.
Scheinberg P, Cooper J, Sloand E, Wu C, Calado R, Young N
. Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemia. JAMA. 2010; 304(12):1358-64.
PMC: 3721502.
DOI: 10.1001/jama.2010.1376.
View
20.
Sun L, Babushok D
. Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria. Blood. 2020; 136(1):36-49.
PMC: 7332901.
DOI: 10.1182/blood.2019000940.
View